72 related articles for article (PubMed ID: 2767722)
1. [Thermographic study of the percutaneous absorption of corticosteroids].
Ippolito F; Di Carlo A; Frascione P
G Ital Dermatol Venereol; 1989; 124(1-2):9-12. PubMed ID: 2767722
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis.
Bickers DR
Cutis; 1984 Aug; 34(2):190-4. PubMed ID: 6383735
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of amcinonide and halcinonide 0.1% ointments in the treatment of psoriasis.
Millikan LE; Mroczkowski TF
Int J Dermatol; 1986 Oct; 25(8):542. PubMed ID: 3533806
[No Abstract] [Full Text] [Related]
4. Stratum corneum absorption kinetics of 2 potent topical corticosteroid formulations: a pilot study.
Draelos ZD
Cutis; 2015 Aug; 96(2):135-41. PubMed ID: 26367752
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of the biphasic release of 0.1% halcinonide cream.
Draelos ZD
J Drugs Dermatol; 2015 Jan; 14(1):89-90. PubMed ID: 25607913
[TBL] [Abstract][Full Text] [Related]
6. A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis.
Guenther L; Solomon AR; Voorhees JJ
Cutis; 1981 Oct; 28(4):461-2, 464, 467. PubMed ID: 7030645
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous absorption of 14C-9alpha-fluoro-11beta,21-dihydroxy-3,20-dioxopregna-1,4-dieno (17alpha,16alpha-d)-2'-methyloxazolidine-21-acetate (L 6400) in rats, pigs and humans. Comparison with 3H-triamcinolone acetonide.
Lewis JD; Cameron BD; Hawkins DR; Chasseaud LF; Franklin ER
Arzneimittelforschung; 1975 Oct; 25(10):1646-50. PubMed ID: 54172
[TBL] [Abstract][Full Text] [Related]
8. Influence of the timing of ultrasound application on the penetration of corticosteroids.
Clijsen R; Baeyens JP; Barel AO; Clarys P
Skin Res Technol; 2013 Feb; 19(1):e279-82. PubMed ID: 22712560
[TBL] [Abstract][Full Text] [Related]
9. [1.0 percent alcinonide ointment, a new topical corticosteroid preparation: clinico-therapeutic evaluation].
Ponzio F; Scalese A; Spagnoli U
Clin Ter; 1980 May; 93(3):295-309. PubMed ID: 7449343
[No Abstract] [Full Text] [Related]
10. [Percutaneous absorption of triamcinolone 16 alpha, 17 alpha cyclopentylene-dioxy-21-acetate (author's transl)].
Meynadier J; Guilhou JJ; Peyron JL
Dermatologica; 1981; 162(5):336-41. PubMed ID: 7250468
[TBL] [Abstract][Full Text] [Related]
11. [Liposomes as drug vehicles in percutaneous therapy].
Krówczyński L; Stozek T
Pharmazie; 1984 Sep; 39(9):627-9. PubMed ID: 6505001
[TBL] [Abstract][Full Text] [Related]
12. [Clinical double blind test with flupamesone and halcinonide].
Ferrandiz Arjonilla L
Rev Clin Esp; 1978 Jun; 149(5):495-7. PubMed ID: 358318
[No Abstract] [Full Text] [Related]
13. [Observations on the clinical use of a topical amphotericin B + halcinonide combination].
Argenziano G; Marino E; Scotti L; Salerno V
Clin Ter; 1988 May; 125(3):213-7. PubMed ID: 2973942
[No Abstract] [Full Text] [Related]
14. [Comparison of 3 corticoid preparations with the vasoconstriction and erythema test].
Früh H
Z Hautkr; 1983 Mar; 58(5):317-23. PubMed ID: 6845798
[TBL] [Abstract][Full Text] [Related]
15. [Pituitary adrenal axis activity during topical treatment with 0,075 g% triamcinolone benetonide cream (author's transl)].
Meynadier J; Guillot B
Dermatologica; 1982 May; 164(5):327-30. PubMed ID: 6284561
[No Abstract] [Full Text] [Related]
16. [Statistic evaluation of a multicentric test with halcinonide].
Bosch Pérez AV; Cisneros Vela JL; Sarro Palau JA
Actas Dermosifiliogr; 1979; 70(1-2):157-74. PubMed ID: 382764
[No Abstract] [Full Text] [Related]
17. The use of halcinonide solution, 0.1 percent, in the treatment of eczematous diseases.
Lynfield YL
Cutis; 1983 Feb; 31(2):203-4. PubMed ID: 6219862
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of corticosteroids: systemic effects.
Scoggins RB; Kliman B
N Engl J Med; 1965 Oct; 273(16):831-40. PubMed ID: 5825903
[No Abstract] [Full Text] [Related]
19. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
Laeijendecker R; Tank B; Dekker SK; Neumann HA
Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
[TBL] [Abstract][Full Text] [Related]
20. [Optimal measurement technic for the vasoconstrictor effect of corticosteroids. Comparative studies with reflection photometry and flow measurement].
Gloor M; Sprenger HJ; Priebe L
Dermatol Monatsschr; 1979 Sep; 165(9):665-9. PubMed ID: 527746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
